AIMS: To assess the effectiveness and to identify predictors for successful electrical
cardioversion (ECV) and maintenance of sinus rhythm, in long term follow up of patients with …

Verapamil and Atrial Fibrillation. Introduction: Many relapses of atrial fibrillation (AF) occur,
especially during the first week (s) after electrical cardioversion (ECV). The aim of the …

Atrial fibrillation (AF) is associated with increased morbidity and mortality, most notably due
to stroke and heart failure. Maintaining sinus rhythm in AF patients is not an easy task, and …

Conversion to sinus rhythm in atrial fibrillation of recent onset has several goals: increased
cardiac output, diminished risk of thromboembolism [1] and, in some patients …

Aims In atrial fibrillation (AF) cardioversion is the cornerstone of the rhythm management
strategy despite the lack of contemporary data on acute and long-term success. We aim to …

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in clinical practice,
and is responsible for considerable morbidity. Basic studies have shown that AF is usually …

Atrial fibrillation is the commonest sustained cardiac arrhythmia. It accounts for> 35% of all
hospital admissions for cardiac arrhythmias in the United States. The presence of atrial …

Aims To evaluate the impact, on atrial fibrillation (AF) recurrences, of verapamil addition to a
class IC or III antiarrhythmic drug in patients, with persistent AF, who underwent an electrical …

Background Elective cardioversion (ECV) of atrial fibrillation (AF) is a standard procedure to
restore sinus rhythm. However, predictors for ineffective ECV (failure of ECV or recurrence of …

Objective: To evaluate prospectively the effects of pretreatment with verapamil on the
maintenance of sinus rhythm after direct current (DC) cardioversion. Design: Randomised …